自動注射器市場：按產品類型、疾病、通路和地區分類

據估計，2026年汽車噴油嘴市場規模為87.246億美元，預計2033年將達到276.6億美元。預計2026年至2033年，該市場將以18%的複合年成長率成長。

自動注射器是一種可以給藥的醫療設備。它們使用方便，患者可以自行給藥。雖然一次性自動注射器最為常見，但可重複使用、可多劑量的自動注射器的研發正在取得顯著進展。自動注射器屬於注射給藥方式，被認為是將藥物有效輸送到目標部位最有效的給藥途徑，從而提高病患的用藥遵從性。注射給藥方式可以促進藥物從皮下、靜脈和肌肉等不同部位的快速吸收。它們還可以提高藥物在體循環中的生物利用度，並確保藥物在預期作用部位發揮作用。腎上腺素自動注射器是一種廣泛用於有過敏反應風險族群的自動注射器。自動注射器包含預填充式注射器或藥筒，透過彈簧機制運作。自動注射器也常被軍方用於保護人員免受化學武器的傷害。

市場動態

預計在預測期內，主要市場參與者採用的產品發佈等非內生成長策略將推動全球自動注射器市場的發展。例如，2020年4月，製藥公司梯瓦製藥宣布推出一款用於預防成人偏頭痛的「AJOVY」自動注射器。這款新型自動注射器具有多項功能，包括操作簡單的無按鈕下壓式機制、用於指示給藥進度的語音提示以及用於顯示給藥完成的指示視窗。

本次調查的主要特點。

• 本報告對全球自動注射器市場進行了詳細分析，以 2021 年為基準年，給出了預測期（2022-2030 年）的市場規模和複合年成長率。
• 本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本報告根據以下參數分析了全球自動注射器市場的主要企業：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球自動注射器市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 研究目標
• 前提
• 簡稱

第2章 市場範圍

• 報告摘要
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機遇
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購與合作情景
• 技術概述
• 法規環境
• PEST分析

第4章 全球自動噴油嘴市場：依產品類型分類，2026-2033年

• 概述
• 預填充
• 可填寫

第5章 全球自動注射器市場：依疾病分類，2026-2033年

• 概述
• 過敏反應
• 多發性硬化症
• 類風濕性關節炎
• 其他疾病（糖尿病、乾癬等）

第6章 全球汽車噴油嘴市場：依通路分類，2026-2033年

• 概述
• 醫院藥房
• 零售藥房
• 網路藥房

第7章 全球汽車噴油嘴市場：依地區分類，2026-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 亞太其他地區
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• Becton, Dickinson and Company
• Sanofi SA
• Takeda Pharmaceutical Company Limited
• Xeris Biopharma Holdings Inc.
• BlackHagen Design
• GSK plc.
• Genentech, Inc.
• AstraZeneca
• Owen Mumford Ltd.
• Stevanato Group
• Jabil Inc.
• Pfizer, Inc.
• Mylan NV
• Novartis AG
• Bayer AG
• Janssen Pharmaceuticals, Inc.
• Antares Pharma
• Eli Lilly and Company
• Amgen, Inc.
• Rafa Laboratories Ltd.
• Halozyme, Inc.
• Biogen
• Teva Pharmaceutical Industries Ltd.

第9章

• 調查方法
• 關於本公司

Auto-Injectors Market is estimated to be valued at USD 8,724.60 Mn in 2026 and is expected to reach USD 27,660.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18% from 2026 to 2033.

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors are disposable and there is a tremendous growth in the development of reusable auto-injectors with multiple dosing. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient's compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors enclose prefilled syringes or cartridges which are driven by a spring system. Auto-injectors are often used in the military to protect personnel from chemical warfare agents.

Market Dynamics

Adoption of inorganic growth strategies such as product launch by key market players is expected to drive the global auto-injectors market over the forecast period. For instance, in April 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, announced that they had launched auto-injector for AJOVY, which is indicated for the preventive treatment of migraine in adults. This new auto-injector has several features such as easy handling including a button-free, push-down mechanism, audible cues that signal progress of administration, and a window that displays when the dose has been delivered.

Key features of the study

• This report provides an in-depth analysis of the global auto-injectors market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global auto-injectors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited, Xeris Biopharma Holdings Inc., BlackHagen Design, GSK plc., Genentech, Inc., AstraZeneca, Owen Mumford Ltd., Stevanato Group, Jabil Inc., Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Pharmaceuticals, Inc., Antares Pharma, Eli Lilly and Company, Amgen Inc., Rafa Laboratories Ltd., Halozyme, Inc., Biogen, and Teva Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global auto-injectors market

Market Segmentation

• By Product Type
  • Prefilled Auto-injectors
  • Fillable Auto-injectors
• By Disease Indication
  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others (Diabetes, Psoriasis, etc.)
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players
  • Becton, Dickinson and Company
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Xeris Biopharma Holdings Inc.
  • BlackHagen Design
  • GSK plc.
  • Genentech, Inc.
  • AstraZeneca
  • Owen Mumford Ltd.
  • Stevanato Group
  • Jabil Inc.
  • Pfizer, Inc.
  • Mylan N.V.
  • Novartis AG
  • Bayer AG
  • Janssen Pharmaceuticals, Inc.
  • Antares Pharma
  • Eli Lilly and Company
  • Amgen Inc.
  • Rafa Laboratories Ltd.
  • Halozyme, Inc.
  • Biogen
  • Teva Pharmaceutical Industries L

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Auto-injectors Market, By Product Type, 2026 - 2033, (USD Mn)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Prefilled Auto-injectors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Fillable Auto-injectors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Auto-injectors Market, By Disease Indication, 2026 - 2033, (USD Mn)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Anaphylaxis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Multiple Sclerosis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others (Diabetes, Psoriasis, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Auto-injectors Market, By Distribution Channel, 2026 - 2033, (USD Mn)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Auto-injectors Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Xeris Biopharma Holdings Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BlackHagen Design
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GSK plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Genentech, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Owen Mumford Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Stevanato Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Jabil Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Janssen Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Antares Pharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amgen, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Rafa Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Halozyme, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biogen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us